TR199903189T2 - Kristalin makrolidler ve haz�rlanmalar�na y�nelik i�lem. - Google Patents

Kristalin makrolidler ve haz�rlanmalar�na y�nelik i�lem.

Info

Publication number
TR199903189T2
TR199903189T2 TR1999/03189T TR9903189T TR199903189T2 TR 199903189 T2 TR199903189 T2 TR 199903189T2 TR 1999/03189 T TR1999/03189 T TR 1999/03189T TR 9903189 T TR9903189 T TR 9903189T TR 199903189 T2 TR199903189 T2 TR 199903189T2
Authority
TR
Turkey
Prior art keywords
formula
preparation
forms
compound
different
Prior art date
Application number
TR1999/03189T
Other languages
English (en)
Turkish (tr)
Inventor
Dosenbach Cornelia
Grassberger Maximilian
Hartmann Otto
Horvath Amarylla
Mutz Jean-Paul
Penn Gerhard
Pfeffer Sabine
Wieckhusen Dierk
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10815103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199903189(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR199903189T2 publication Critical patent/TR199903189T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Metallurgy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR1999/03189T 1997-06-30 1998-06-26 Kristalin makrolidler ve haz�rlanmalar�na y�nelik i�lem. TR199903189T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9713730.1A GB9713730D0 (en) 1997-06-30 1997-06-30 Organic compounds

Publications (1)

Publication Number Publication Date
TR199903189T2 true TR199903189T2 (xx) 2000-06-21

Family

ID=10815103

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03189T TR199903189T2 (xx) 1997-06-30 1998-06-26 Kristalin makrolidler ve haz�rlanmalar�na y�nelik i�lem.

Country Status (32)

Country Link
US (1) US6423722B1 (zh)
EP (1) EP0994880B1 (zh)
JP (2) JP3880634B2 (zh)
KR (1) KR100399765B1 (zh)
CN (1) CN1139595C (zh)
AR (1) AR017754A1 (zh)
AT (1) ATE287410T1 (zh)
AU (1) AU739211B2 (zh)
BR (1) BR9810956A (zh)
CA (1) CA2290412C (zh)
CO (1) CO4940463A1 (zh)
CZ (1) CZ297244B6 (zh)
DE (1) DE69828692T2 (zh)
DK (1) DK0994880T3 (zh)
ES (1) ES2236922T3 (zh)
GB (1) GB9713730D0 (zh)
HK (1) HK1028597A1 (zh)
HU (1) HU227755B1 (zh)
ID (1) ID24897A (zh)
IL (1) IL132761A0 (zh)
MY (1) MY118718A (zh)
NO (1) NO312765B1 (zh)
NZ (1) NZ500994A (zh)
PE (1) PE97699A1 (zh)
PL (1) PL192761B1 (zh)
PT (1) PT994880E (zh)
RU (1) RU2219181C2 (zh)
SK (1) SK285665B6 (zh)
TR (1) TR199903189T2 (zh)
TW (1) TW552264B (zh)
WO (1) WO1999001458A1 (zh)
ZA (1) ZA985655B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
EP2181995A3 (en) * 2003-09-03 2010-06-16 Glaxo Group Limited Salts and crystalline form of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-sufanyl)-acetate
JP2007523069A (ja) * 2004-12-01 2007-08-16 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 非吸湿性及び粉末性非晶質ピメクロリマス
US20090082386A1 (en) * 2006-11-06 2009-03-26 Erzsebet Meszarosne Sos Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
EP2451496B1 (en) 2009-07-10 2015-07-22 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
EP2453938B1 (en) 2009-07-17 2015-08-19 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013022458A1 (en) * 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
SG11201507406YA (en) * 2013-03-15 2015-10-29 Biosensors Int Group Ltd Purification of rapamycin derivatives
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
HRP20220203T1 (hr) * 2017-05-01 2022-05-27 Meda Pharma Gmbh & Co. Kg Postupak pretvaranja sirovog askomicina u pročišćeni pimekrolimus
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
GB2084580B (en) 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
JP2728482B2 (ja) * 1989-01-26 1998-03-18 協和醗酵工業株式会社 マクロライド系抗生物質の精製法
EP0433428B1 (en) 1989-07-10 1994-10-12 Chemferm V.O.F. A stable form of cephradine, process for its production and intermediates used therein
EP0427680B1 (en) * 1989-11-09 1995-08-23 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
JPH05505798A (ja) * 1990-03-13 1993-08-26 フアイソンズ・ピーエルシー 免疫抑制マクロ環状化合物
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
DK0526171T3 (da) 1991-07-30 1997-08-25 Ajinomoto Kk Krystaller af N-(trans-4-isopropylcyclohexylcarbonyl)-Dphenylalanin og fremgangsmåder til fremstilling deraf
US5247076A (en) 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5221740A (en) 1992-01-16 1993-06-22 American Home Products Corporation Oxepane isomers of rapamycin useful as immunosuppressive agents
UA41884C2 (uk) * 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
WO1995022390A1 (en) * 1994-02-22 1995-08-24 Curators Of The University Of Missouri Macrocyclic antibiotics as separation agents
JPH11512096A (ja) * 1995-08-24 1999-10-19 メルク エンド カンパニー インコーポレーテッド イミダゾリルマクロライド免疫抑制剤の製造方法
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds

Also Published As

Publication number Publication date
ATE287410T1 (de) 2005-02-15
HK1028597A1 (en) 2001-02-23
PE97699A1 (es) 1999-10-29
CA2290412A1 (en) 1999-01-14
HU227755B1 (en) 2012-02-28
CZ297244B6 (cs) 2006-10-11
DE69828692D1 (de) 2005-02-24
CO4940463A1 (es) 2000-07-24
SK186699A3 (en) 2000-05-16
MY118718A (en) 2005-01-31
JP2001506279A (ja) 2001-05-15
EP0994880A1 (en) 2000-04-26
HUP0003053A3 (en) 2003-03-28
TW552264B (en) 2003-09-11
US6423722B1 (en) 2002-07-23
JP3880634B2 (ja) 2007-02-14
DK0994880T3 (da) 2005-05-30
KR20010020423A (ko) 2001-03-15
CN1261365A (zh) 2000-07-26
WO1999001458A1 (en) 1999-01-14
AU8540998A (en) 1999-01-25
BR9810956A (pt) 2000-09-26
DE69828692T2 (de) 2006-01-12
IL132761A0 (en) 2001-03-19
CN1139595C (zh) 2004-02-25
GB9713730D0 (en) 1997-09-03
CA2290412C (en) 2009-11-10
EP0994880B1 (en) 2005-01-19
AU739211B2 (en) 2001-10-04
NZ500994A (en) 2001-08-31
JP2006151999A (ja) 2006-06-15
SK285665B6 (sk) 2007-05-03
AR017754A1 (es) 2001-10-24
NO995909D0 (no) 1999-12-02
PT994880E (pt) 2005-06-30
ZA985655B (en) 1998-12-30
KR100399765B1 (ko) 2003-09-29
ES2236922T3 (es) 2005-07-16
NO995909L (no) 1999-12-02
RU2219181C2 (ru) 2003-12-20
HUP0003053A2 (hu) 2001-02-28
NO312765B1 (no) 2002-07-01
PL336719A1 (en) 2000-07-03
ID24897A (id) 2000-08-31
JP4504323B2 (ja) 2010-07-14
PL192761B1 (pl) 2006-12-29
CZ474099A3 (cs) 2000-04-12

Similar Documents

Publication Publication Date Title
TR199903189T2 (xx) Kristalin makrolidler ve haz�rlanmalar�na y�nelik i�lem.
RU2196769C2 (ru) Производные аминобензойной кислоты, фармацевтическая композиция
NO2006003I1 (no) ÄR-(R*R*)-N-Ä3-Ä1-Ä5,6-dihydro-4-hydroksy-2-okso-6-(2-fenyletyl)-6-propyl-2H-pyran-3-yl)ÜpropylÜfenylÜ5-(trifluormetyl)-2-pyridinsulfonamid eller et farmasoytisk salt derav = tipranavir eller et farmasoytisk salt derav
NO881933D0 (no) Orale administreringsformer med forsinket avgivning.
DK0912405T3 (da) Æske og råemne til dannelse af samme
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
ME00768B (me) Derivati supstituisanih benzol sulfonamida kao pro-lekovi cox-2 inhibitora
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
DE69531682D1 (de) Sterolderivate für die regulierung der meiose
EA199901016A1 (ru) 9-оксим-производные эритромицина
NO995108D0 (no) 2-okso-1-azetidinsulfonsyrederivater som potente <beta>-laktamase inhibitorer
TR200100700T2 (tr) EtO2C--CH2-(R)Cgl-Aze-Pab-OH'nin kristalin formları
BR9909468A (pt) Composto anti-bacteriano, composição oral anti-placas, e, processo para promoção da higiene oral
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
RU2000101826A (ru) Кристаллические макролиды и способ их получения
CA2337098A1 (en) Anthranilic acid derivatives
PT1361987E (pt) Folha de caixa planificada e caixa montada em especial para cigarros
CA2326815A1 (en) Process for preparation of pyridine derivatives
BR1100548KB1 (pt) processos para a preparação de derivados de ácido n-acetil neuramìnico cristalino.
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
IT1282286B1 (it) Seco-d steroidi sul sistema cardiovascolare, processi per la loro preparazione e composizioni farmaceutiche che li contengono.
TR200003131T2 (tr) Bir ß-laktam antibiyotik kristallendirme yöntemi
TR199800210T2 (xx) Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlar�n �retimi i�in i�lemler.